ProCE Banner Activity

The New Standard of Care: Leveraging the Benefits of SGLT2 Inhibitors Across the Heart Failure Spectrum


Download this slide set to review strategies on how to incorporate SGLT2 inhibitors into a variety of heart failure patients with varying ejection fractions.

Released: October 04, 2023



Javed Butler

Javed Butler, MD, MPH, MBA

Baylor Scott and White Research Institute
Dallas, Texas
Distinguished Professor of Medicine
Department of Medicine
University of Mississippi Medical Center
Jackson, Mississippi

Lee R. Goldberg

Lee R. Goldberg, MD, MPH, FACC, FAHA, FHFSA

Vice Chair of Medicine for Informatics
Section Chief, Advanced Heart Failure and Cardiac Transplant
Professor of Medicine
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


This activity is supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.

Boehringer Ingelheim Pharmaceuticals, Inc.

Eli Lilly and Company